Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting

BACKGROUND: Since oral direct-acting antiviral agents (DAAs) became available, the global hepatitis C treatment situation has undergone tremendous changes. However there are still many issues worthy of attention in treatment. METHODS: We selected 53 HCV-infected patients who were treated and followe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongyu, Liu, Jianxiang, Kang, Qian, Luo, Hao, Tan, Ning, Pan, Jiali, Yang, Yuqing, Yu, Min, Liu, Dan, Xi, Hongli, Han, Yifan, Cheng, Ran, Yu, Yanyan, Xu, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250317/
https://www.ncbi.nlm.nih.gov/pubmed/35789797
http://dx.doi.org/10.2147/IDR.S352873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250317/
https://www.ncbi.nlm.nih.gov/pubmed/35789797
http://dx.doi.org/10.2147/IDR.S352873

Ejemplares similares